Back to today’s briefing

Story perspectives

Sleep Aid Shows Promise in Reducing Alzheimer’s Proteins

4/3/2025

31 4

Summary

Story summary

A groundbreaking study from Washington University in St. Louis reveals that the sleep aid suvorexant could potentially lower amyloid-beta and tau proteins associated with Alzheimer's disease. Participants experienced a promising 10-20% reduction in amyloid-beta levels. Yet, the shadow of long-term effects and dependency looms, highlighting the need for further investigation.

1 of 1

Story summary

A groundbreaking study from Washington University in St. Louis reveals that the sleep aid suvorexant could potentially lower amyloid-beta and tau proteins associated with Alzheimer's disease. Participants experienced a promising 10-20% reduction in amyloid-beta levels. Yet, the shadow of long-term effects and dependency looms, highlighting the need for further investigation.